UK markets closed

Orthofix Medical Inc. (OFIX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.01-0.10 (-0.66%)
As of 03:57PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 567.07M
Enterprise value 677.37M
Trailing P/E N/A
Forward P/E 20.04
PEG ratio (5-yr expected) 0.33
Price/sales (ttm)0.74
Price/book (mrq)0.99
Enterprise value/revenue 0.89
Enterprise value/EBITDA 34.53

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3-23.96%
S&P500 52-week change 326.36%
52-week high 321.60
52-week low 39.57
50-day moving average 313.85
200-day moving average 313.87

Share statistics

Avg vol (3-month) 3349.75k
Avg vol (10-day) 3418.13k
Shares outstanding 537.53M
Implied shares outstanding 637.53M
Float 825.96M
% held by insiders 14.36%
% held by institutions 196.99%
Shares short (30 Apr 2024) 44.05M
Short ratio (30 Apr 2024) 413.93
Short % of float (30 Apr 2024) 411.09%
Short % of shares outstanding (30 Apr 2024) 410.80%
Shares short (prior month 28 Mar 2024) 43.84M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -16.64%
Operating margin (ttm)-16.17%

Management effectiveness

Return on assets (ttm)-2.78%
Return on equity (ttm)-20.49%

Income statement

Revenue (ttm)760.04M
Revenue per share (ttm)20.41
Quarterly revenue growth (yoy)7.70%
Gross profit (ttm)N/A
EBITDA 21.98M
Net income avi to common (ttm)-126.48M
Diluted EPS (ttm)-3.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.3M
Total cash per share (mrq)0.75
Total debt (mrq)157.17M
Total debt/equity (mrq)27.56%
Current ratio (mrq)2.65
Book value per share (mrq)15.24

Cash flow statement

Operating cash flow (ttm)-30.33M
Levered free cash flow (ttm)-831.88k